Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Orthofix Medical Inc.

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

NuVasive, Inc.

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

SeaSpine Holdings Corporation

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Orthofix Medical Inc. Common Stock (DE)

Orthofix provides medical devices and solutions aimed at improving patient mobility through innovations in spine and orthopedic care. self-described.

Metric
Company Name	Orthofix Medical Inc.	NuVasive, Inc.	SeaSpine Holdings Corporation
Symbol	OFIX	NUVA	SPNE
MSH ID	COM:ORTHOFIX	COM:NUVASIVE	COM:SEASPINE
Market	STOCKS	STOCKS	STOCKS
Sector	Healthcare	Healthcare	Healthcare
Industry	Medical - Devices	Medical - Devices	Medical - Devices
Country	US	US	US
Stage
Employee Count	1.63K	3K	523
Website	orthofix.com	nuvasive.com	seaspine.com
LinkedIn
Founders

Metric
Market Cap	560.31M	2.08B
Enterprise Value
Monthly Web Traffic			1.86K
Web Traffic Growth			-0.23
Valuation
Raised Capital

Metric
Revenue	746.64M	1.20B	191.45M
Revenue (LTM)
Revenue (NTM)
Gross Profit	468.87M	865.43M	114.59M
EBITDA	-88.70M	211.80M	-55.45M
Operating Income	-141.76M	64.77M	-60.98M
Net Income	-151.40M	40.41M	-54.35M
EPS	-4.12	0.78	-1.62
Diluted EPS	-4.12	0.76	-1.62
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.66	0.72	0.60
Operating Profit Margin	-0.12	0.08	-0.32
EBITDA Margin	-0.12	0.18	-0.29
Net Profit Margin	-0.16	0.03	-0.28
Return on Equity	-0.21	0.03	-0.22
Return on Assets	-0.14	0.01	-0.14
Return on Capital Employed	-0.12	0.05	-0.19

COM:ORTHOFIX

Orthofix

Last Close

18.68

22/11 21:00

Market Cap

666.07M

Beta: -

Volume Today

302.28K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-3.83	73.24	-7.67
P/B Ratio	0.85	2.33	1.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.86	2.24
EV Multiple	-3.69	8.48	-1.35

Metric
Days Sales Outstanding	62.31	79.51	81.67
Days Payables Outstanding	84.66	124.79	98.11
Days Inventory Outstanding	306.42	480.24	343.32
Operating Cycle	369.04	584.96	412.40
Cash Conversion Cycle	288.55	422.32	315.99
Asset Turnover	0.87	0.59	0.51

Metric
Operating Cash Flow	-45.75M	169.12M	-33.51M
Free Cash Flow	-107.80M	29.69M	-59.55M
Cash Flow to Debt	-0.12	0.15	-4.14
Operating Cash Flow/Sales	-0.02	0.11	-0.18
Free Cash Flow Yield	-0.17	-0.00

Metric
Cash & Equivalents	37.76M	248.66M	83.11M
Accounts Receivable	-10.41M	-37.18M	-7.93M
Inventory	222.17M	338.60M	72.30M
Goodwill	194.93M	639.66M	84.59M
Debt to Capitalization	0.20	0.50	0.03
Debt to Assets	0.10	0.43	0.12
Current Ratio	2.58	1.25	3.18
Quick Ratio	1.19	0.60	2.25

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.06	0.02	0.06
R&D to Revenue	0.11	0.08	0.10
SG&A to Revenue	0.20		0.22